Stock listing
Dusseldorf:9EP Enanta Pharmaceuticals, Inc. Aktie
German listing (Dusseldorf) of Enanta Pharmaceuticals, Inc. · home listing NASDAQ:ENTA
Follow Enanta Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:ENTA
$10.43 USD -0.28 (-2.6%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:ENTA
- Day range
- $10.14 – $10.91 USDNov 2, 2026
- Volume
- 350,518 sharesNov 2, 2026
- Market cap
- $303.8M USDAt the close on Nov 2, 2026 · price × 29.13M shares outstanding
- 52-week range
- $10.14 – $17.15 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $3.17M USDMedian day 218,875 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ENTA · Home | $10.43 USD | -0.28 (-2.6%) | 350,518 | $10.74 | $10.91 | $10.14 | $10.71 | Close on Nov 2, 2026 |
| Frankfurt:9EP | €9.40 EUR | -1.30 (-12.1%) | — | €9.65 | €9.70 | €9.40 | €10.70 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:ENTA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $10.43 | -0.28 | -2.6% | $10.74 | $10.91 | $10.14 | 350,518 | |
| $10.71 | -0.44 | -3.9% | $11.08 | $11.10 | $10.69 | 202,338 | |
| $11.15 | -0.40 | -3.5% | $11.65 | $11.74 | $10.76 | 218,488 | |
| $11.55 | -0.63 | -5.2% | $11.20 | $11.77 | $10.70 | 282,000 | |
| $12.18 | +0.18 | +1.5% | $11.98 | $12.40 | $11.86 | 319,426 | |
| $12.00 | +0.36 | +3.1% | $11.73 | $12.06 | $11.65 | 440,614 | |
| $11.64 | +0.02 | +0.2% | $11.57 | $11.68 | $10.97 | 228,231 | |
| $11.62 | +0.31 | +2.7% | $11.31 | $11.63 | $11.09 | 200,625 | |
| $11.31 | -0.36 | -3.1% | $11.64 | $11.85 | $11.24 | 166,827 | |
| $11.67 | +0.26 | +2.3% | $11.43 | $11.85 | $11.41 | 164,922 | |
| $11.41 | +0.31 | +2.8% | $11.14 | $11.76 | $11.00 | 293,409 | |
| $11.10 | -0.37 | -3.2% | $11.65 | $11.65 | $10.95 | 215,413 | |
| $11.47 | +0.29 | +2.6% | $11.34 | $11.75 | $11.22 | 178,425 | |
| $11.18 | -0.34 | -3.0% | $11.44 | $11.57 | $11.15 | 227,614 | |
| $11.52 | -0.78 | -6.3% | $12.37 | $12.37 | $11.39 | 173,991 | |
| $12.30 | -0.20 | -1.6% | $12.48 | $12.64 | $12.15 | 122,894 | |
| $12.50 | +0.40 | +3.3% | $12.07 | $12.61 | $12.07 | 182,070 | |
| $12.10 | -0.27 | -2.2% | $12.26 | $12.35 | $11.70 | 282,900 | |
| $12.37 | +0.20 | +1.6% | $12.09 | $12.57 | $12.05 | 191,666 | |
| $12.17 | -0.43 | -3.4% | $12.66 | $12.66 | $11.97 | 271,696 | |
| $12.60 | -0.36 | -2.8% | $12.95 | $13.03 | $12.47 | 218,875 | |
| $12.96 | +0.12 | +0.9% | $13.20 | $13.21 | $12.58 | 748,004 | |
| $12.84 | -0.34 | -2.6% | $13.08 | $13.45 | $12.83 | 331,488 | |
| $13.18 | +0.54 | +4.3% | $12.67 | $13.41 | $12.44 | 425,884 | |
| $12.64 | +0.025 | +0.2% | $12.62 | $12.85 | $12.43 | 322,820 | |
| $12.62 | +0.735 | +6.2% | $11.88 | $12.68 | $11.69 | 349,328 | |
| $11.88 | -0.12 | -1.0% | $11.99 | $12.00 | $11.64 | 217,317 | |
| $12.00 | +0.05 | +0.4% | $11.94 | $12.02 | $11.67 | 206,240 | |
| $11.95 | -0.47 | -3.8% | $12.33 | $12.33 | $11.87 | 206,321 | |
| $12.42 | +0.31 | +2.6% | $12.24 | $12.47 | $12.03 | 164,646 | |
| $12.11 | -0.09 | -0.7% | $12.28 | $12.28 | $11.94 | 217,213 | |
| $12.20 | -0.32 | -2.6% | $12.49 | $12.61 | $12.19 | 428,245 | |
| $12.52 | -0.18 | -1.4% | $12.67 | $12.84 | $12.49 | 277,682 | |
| $12.70 | +0.41 | +3.3% | $12.33 | $12.92 | $12.33 | 267,530 | |
| $12.29 | -0.83 | -6.3% | $13.07 | $13.07 | $12.16 | 284,879 | |
| $13.12 | +0.16 | +1.2% | $12.81 | $13.13 | $12.79 | 280,241 | |
| $12.96 | +0.26 | +2.0% | $12.83 | $13.04 | $12.59 | 289,137 | |
| $12.70 | -0.54 | -4.1% | $13.09 | $13.21 | $12.44 | 312,792 | |
| $13.24 | -0.26 | -1.9% | $13.50 | $13.51 | $13.09 | 192,952 | |
| $13.50 | -0.58 | -4.1% | $13.91 | $13.91 | $13.43 | 158,196 | |
| $14.08 | +0.06 | +0.4% | $13.92 | $14.23 | $13.45 | 233,450 | |
| $14.02 | -0.07 | -0.5% | $14.17 | $14.29 | $13.85 | 239,350 | |
| $14.09 | +0.58 | +4.3% | $13.56 | $14.19 | $13.48 | 251,783 | |
| $13.51 | +0.18 | +1.4% | $13.34 | $13.64 | $13.25 | 217,295 | |
| $13.33 | -0.27 | -2.0% | $13.52 | $13.60 | $13.12 | 286,516 | |
| $13.60 | -0.20 | -1.4% | $13.72 | $13.91 | $13.47 | 155,915 | |
| $13.80 | -0.35 | -2.5% | $14.08 | $14.18 | $13.76 | 280,234 | |
| $14.15 | +0.07 | +0.5% | $14.00 | $14.37 | $13.75 | 156,203 | |
| $14.08 | -0.02 | -0.1% | $14.06 | $15.05 | $14.02 | 407,078 | |
| $14.10 | +0.63 | +4.7% | $13.44 | $14.27 | $12.83 | 357,439 | |
| $13.47 | +0.34 | +2.6% | $13.27 | $13.70 | $13.09 | 335,246 | |
| $13.13 | -0.38 | -2.8% | $13.42 | $13.50 | $12.93 | 194,821 | |
| $13.51 | +0.21 | +1.6% | $13.51 | $13.63 | $13.16 | 187,392 | |
| $13.30 | +0.47 | +3.7% | $12.80 | $13.42 | $12.80 | 196,630 | |
| $12.83 | -0.33 | -2.5% | $13.13 | $13.32 | $12.59 | 314,792 | |
| $13.16 | -0.28 | -2.1% | $13.38 | $13.40 | $12.96 | 173,405 | |
| $13.44 | -0.06 | -0.4% | $13.57 | $13.99 | $13.44 | 152,715 | |
| $13.50 | -0.02 | -0.1% | $13.48 | $13.68 | $13.27 | 149,824 | |
| $13.52 | -0.29 | -2.1% | $13.74 | $13.82 | $12.71 | 200,170 | |
| $13.81 | +0.04 | +0.3% | $13.73 | $13.86 | $13.64 | 147,586 | |
| $13.77 | +0.43 | +3.2% | $13.43 | $13.87 | $13.35 | 182,991 | |
| $13.34 | +0.12 | +0.9% | $13.27 | $13.54 | $13.19 | 220,703 | |
| $13.22 | -0.10 | -0.8% | $13.40 | $13.68 | $13.03 | 230,044 | |
| $13.32 | +0.37 | +2.9% | $13.05 | $13.63 | $12.71 | 209,591 | |
| $12.95 | +0.35 | +2.8% | $12.70 | $12.97 | $12.34 | 168,147 |
- Ticker
- Dusseldorf:9EP
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Dusseldorf
- Currency
- EUR
What changed lately
Latest news release · Oct 28, 2026
Enanta Pharmaceuticals Announces Planned Retirement of Longstanding Chief Executive Officer Jay R. Luly, Ph.D. After 23 Years of Company Leadership
Latest deck · Sep 14, 2026
Investor Presentation (September 2026)
Investor deck · 39 slides
Calls
Replays
Enanta Pharmaceuticals (NASDAQ:ENTA) Q2 2024 Earnings Call
Mon, May 06, 2024 · 4:30 PM ET
Watch TranscriptEnanta Pharmaceuticals (NASDAQ:ENTA) Q1 2024 Earnings Call
Wed, Feb 07, 2024 · 4:30 PM ET
Watch TranscriptEnanta Pharmaceuticals (NASDAQ:ENTA) Q4 2023 Earnings Call
Mon, Nov 20, 2023 · 4:30 PM ET
Watch Transcript
Latest news
Enanta Pharmaceuticals Announces Planned Retirement of Longstanding Chief Executive Officer Jay R. Luly, Ph.D. After 23 Years of Company Leadership
Oct 28, 2026
Closed $11.55 (-5.2%) on Oct 28, 2026
Enanta Pharmaceuticals Announces First Patient Dosed in the RESOLVE Phase 2b/3 Study of Zelicapavir, a Potential First-in-Disease Treatment for Respiratory Syncytial Virus (RSV)
Oct 26, 2026
Closed $12.00 (+3.1%) on Oct 26, 2026
Enanta Pharmaceuticals to Present Data for Zelicapavir, an Oral, Once-Daily, N-Protein Inhibitor, in Development for the Treatment of Respiratory Syncytial Virus, at IDWeek™ 2026
Oct 13, 2026
Closed $11.52 (-6.3%) on Oct 13, 2026
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2026
Aug 10, 2026
Closed $13.52 (-2.1%) on Aug 11, 2026
Enanta Pharmaceuticals’ Partner AbbVie Receives European Commission Approval of MAVIRET® (Glecaprevir/Pibrentasvir) for People with Acute Hepatitis C Virus
Jun 23, 2026
Closed $14.06 (+5.2%) on Jun 23, 2026
Enanta Pharmaceuticals Announces Advancement of its Zelicapavir Clinical Development Program for the Treatment of Respiratory Syncytial Virus
Jun 19, 2026
Closed $13.37 (+5.6%) on Jun 22, 2026
Enanta Pharmaceuticals Announces Advancement of its Zelicapavir Clinical Development Program for the Treatment of Respiratory Syncytial Virus (RSV)
Jun 18, 2026
Closed $12.66 (+0.2%) on Jun 18, 2026
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2026
May 11, 2026
Closed $14.53 (-6.0%) on May 12, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 39 slides · Sep 14, 2026
Corporate Update (June 2026)
Corporate update · 29 slides · Jun 18, 2026
ATS 2026 International Conference
Conference · 14 slides · May 2026
ESCMID Global 2026
Conference · 13 slides · Apr 18, 2026
Enanta Pharmaceuticals, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 20 in the last 12 months · 149 in all · newest Oct 28, 2026 · oldest 2019
- Calls
- 15 calls with a replay · 15 with a transcript · latest May 6, 2024
- Decks
- 16 decks · latest Sep 14, 2026
Where Enanta Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ENTA · Home listing | NASDAQ | United States | USD |
| gettex:9EP | gettex | Germany | EUR |
| LS Exchange:A1T7BJ | LS Exchange | Germany | EUR |
| Lang & Schwarz:A1T7BJ | Lang & Schwarz | Germany | EUR |
| Tradegate:9EP | Tradegate | Germany | EUR |
| BOATS:ENTA | BOATS | United States | USD |
| Munich:9EP | Munich | Germany | EUR |
| BX Swiss:9EP | BX Swiss | Switzerland | CHF |
| Dusseldorf:9EP · This page | Dusseldorf | Germany | EUR |
| Frankfurt:9EP | Frankfurt | Germany | EUR |
| Stuttgart:9EP | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Enanta Pharmaceuticals, Inc.